Benitec Biopharma Inc. BNTC Stock
5.5 USD
{{ price }}
-11.646585%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
14.26M USD
LOW - HIGH [24H]
5.31
-
6.23 USD
VOLUME [24H]
38.01K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-236.13 USD
Benitec Biopharma Inc. Price Chart
Benitec Biopharma Inc. BNTC Financial and Trading Overview
| Benitec Biopharma Inc. stock price | 5.5 USD |
| Previous Close | 0.23 USD |
| Open | 0.23 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1000 |
| Day's Range | 0.23 - 0.24 USD |
| 52 Week Range | 0.13 - 2.1 USD |
| Volume | 94.73K USD |
| Avg. Volume | 296.19K USD |
| Market Cap | 6.57M USD |
| Beta (5Y Monthly) | 1.141901 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -236.13 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4 USD |
BNTC Valuation Measures
| Enterprise Value | 605.6K USD |
| Trailing P/E | N/A |
| Forward P/E | -0.24726316 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 96.658585 |
| Price/Book (mrq) | 1.3982143 |
| Enterprise Value/Revenue | 8.906 |
| Enterprise Value/EBITDA | -0.032 |
Trading Information
Benitec Biopharma Inc. Stock Price History
| Beta (5Y Monthly) | 1.141901 |
| 52-Week Change | -73.88% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.1 USD |
| 52 Week Low | 0.13 USD |
| 50-Day Moving Average | 0.22 USD |
| 200-Day Moving Average | 0.25 USD |
BNTC Share Statistics
| Avg. Volume (3 month) | 296.19K USD |
| Avg. Daily Volume (10-Days) | 120.92K USD |
| Shares Outstanding | 27.98M |
| Float | 24.42M |
| Short Ratio | 0.66 |
| % Held by Insiders | 7.92% |
| % Held by Institutions | 52.09% |
| Shares Short | 254.31K |
| Short % of Float | 1.41% |
| Short % of Shares Outstanding | 0.91% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:3 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -28336.76% |
| Gross Margin | 86.76% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -131.73% |
| Return on Equity (ttm) | -326.46% |
Income Statement
| Revenue (ttm) | 68K USD |
| Revenue Per Share (ttm) | 0.004 USD |
| Quarterly Revenue Growth (yoy) | 12.50% |
| Gross Profit (ttm) | 64K USD |
| EBITDA | -19148000 USD |
| Net Income Avi to Common (ttm) | -19968000 USD |
| Diluted EPS (ttm) | -1.28 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.55M USD |
| Total Cash Per Share (mrq) | 0.23 USD |
| Total Debt (mrq) | 623K USD |
| Total Debt/Equity (mrq) | 13.22 USD |
| Current Ratio (mrq) | 2.345 |
| Book Value Per Share (mrq) | 0.168 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18772000 USD |
| Levered Free Cash Flow (ttm) | -10651000 USD |
Profile of Benitec Biopharma Inc.
| Country | United States |
| State | CA |
| City | Hayward |
| Address | 3940 Trust Way |
| ZIP | 94545 |
| Phone | 510 780 0819 |
| Website | https://benitec.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 18 |
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.
Q&A For Benitec Biopharma Inc. Stock
What is a current BNTC stock price?
Benitec Biopharma Inc. BNTC stock price today per share is 5.5 USD.
How to purchase Benitec Biopharma Inc. stock?
You can buy BNTC shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Benitec Biopharma Inc.?
The stock symbol or ticker of Benitec Biopharma Inc. is BNTC.
Which industry does the Benitec Biopharma Inc. company belong to?
The Benitec Biopharma Inc. industry is Biotechnology.
How many shares does Benitec Biopharma Inc. have in circulation?
The max supply of Benitec Biopharma Inc. shares is 2.59M.
What is Benitec Biopharma Inc. Price to Earnings Ratio (PE Ratio)?
Benitec Biopharma Inc. PE Ratio is now.
What was Benitec Biopharma Inc. earnings per share over the trailing 12 months (TTM)?
Benitec Biopharma Inc. EPS is -236.13 USD over the trailing 12 months.
Which sector does the Benitec Biopharma Inc. company belong to?
The Benitec Biopharma Inc. sector is Healthcare.
Benitec Biopharma Inc. BNTC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
- {{ link.label }} {{link}}